United States · B2B startup

Twist Bioscience

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Funding reportedLast round: Post-IPO Equity

B2BSan Francisco, United States

What company datasets say Twist Bioscience raised

Funding, as reported

Reported in all$250Min dollars
Last roundPost-IPO Equity
Investors listed5
SEC Form D$407M sold, 11 filings, last Apr 2018

Founders and team

From Twist Bioscience's own website and the SEC filings it signed: 1 founder, 16 on the team.

Keith Marine CrandellCo-Founder and Managing DirectorNamed on its 2018 Form D
  • Patrick FinnPresident and Chief Operating Officer
  • Emily Marine LeproustChief Executive Officer
  • Jimmy JinSenior Vice President of Product and Marketing
  • Mark BuckSenior Vice President of Operations
  • Nicole MorenoSenior Vice President of Sales and Support
  • Paula GreenSenior Vice President of Human Resources
  • Bob Marine RagusaCEO
  • Adam LaponisChief Financial Officer
  • Dennis ChoChief Legal Officer and Corporate Secretary
  • Mike FeroChief Information Officer
  • Siyuan ChenChief Technology Officer
  • Nelson C. ChanChairman of the Board
  • Stock Quote ChartAnalyst Coverage
  • Bill Marine PeckExecutive Officeri
  • Rob Marine ChessChairman of the Board of Directors
  • William Marine BanyaiExecutive Officer, Directori

On the board, as filediFred Marine CravesMinqi Marine LiPaul Marine Conley

AdvisersJan Johannessen

On 8 portfolio pages

Investors who name them

Each firm lists Twist Bioscience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

B2B in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Twist Bioscience in front of investors. Or tell us what we have wrong.

List your startupSend a correction